abstract: Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer (astounding figures) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, March 27, 2012

abstract: Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer (astounding figures)



Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer - NCBI

Abstract

OBJECTIVE:

To determine the potential economic impact of a paclitaxel drug shortage in patients with newly diagnosed, untreated ovarian cancer.

RESULTS:

...... A drug shortage that affects approximately 50% of women initiating chemotherapy is expected to impact 779 women and cost third party payers an additional $8,699,872 monthly.

CONCLUSIONS:

Our model indicates that chemotherapy drug shortages can have a significant negative impact on the average cost of primary treatment for ovarian cancer and have the potential to negatively impact health system costs.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.